Levodopa use and sleep in patients with dementia with Lewy bodies

Movement Disorders

Volumn 24, Issue 4, 2009, Pages 609-612

  Molloy, Sophie ^a,c   Minett, Thais ^b   O'Brien, John T ^a   McKeith, Ian G ^a   Burn, David J ^a  

^a NEWCASTLE UNIVERSITY   (United Kingdom)

^b FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

^c CHARING CROSS HOSPITAL   (United Kingdom)

Author keywords

Dementia with Lewy bodies; Levodopa; Sleep

Indexed keywords

LEVODOPA; ANTIPARKINSON AGENT;

AGE DISTRIBUTION; AGED; ARTICLE; CLINICAL ARTICLE; COGNITION; CONTROLLED STUDY; DAYTIME SOMNOLENCE; DIFFUSE LEWY BODY DISEASE; DISEASE SEVERITY; DOSE RESPONSE; DRUG DOSE TITRATION; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; EPWORTH SLEEPINESS SCALE; FEMALE; HUMAN; MALE; MINI MENTAL STATE EXAMINATION; MOTOR PERFORMANCE; PARKINSON DISEASE; PILOT STUDY; PRIORITY JOURNAL; SEX DIFFERENCE; SLEEP DISORDER; TREATMENT DURATION; CLINICAL TRIAL; COMPARATIVE STUDY; HOSPITALIZATION; MENTAL HEALTH; QUESTIONNAIRE; TIME;

AGED; AGED, 80 AND OVER; ANTIPARKINSON AGENTS; FEMALE; HUMANS; LEVODOPA; LEWY BODY DISEASE; MALE; MENTAL STATUS SCHEDULE; PARKINSON DISEASE; QUESTIONNAIRES; SEVERITY OF ILLNESS INDEX; SLEEP DISORDERS; TIME FACTORS;

EID: 67651154375     PISSN: 08853185     EISSN: 15318257     Source Type: Journal    
DOI: 10.1002/mds.22411     Document Type: Article

References (27)

1. Comella CL. Sleep disorders in Parkinson's disease: an overview. Mov Disord 2007;22:S367-S373.
2. Molloy S, O'Brien JT, McKeith IG, et al. The role of levodopa in the management of dementia with Lewy bodies. J Neurol Neurosurg Psychiatry 2005;76:1200-1203.
3. Molloy S, Rowan EN, McKeith IG, et al. The effect of levodopa on cognitive function in Parkinson's diease with and without dementia and dementia with Lewy bodies. J Neurol Neurosurg Psychiatry 2006;77:1323-1328.
4. Mc Keith IG, Galasko D, Kosaka K, et al. Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB): report on the consortium on DLB international workshop. Neurology 1996;47:1113-1124.
5. Gibb WRG, Lees AJ. The relevance of the Lewy body to the pathogenesis of idiopathic Parkinson's disease. J Neurol Neurosurg Psychiatry 1988;51:745-752.
6. Fahn S, Elton RL, and the Members of the UPDRS Development Committee. Uni.ed Parkinson's disease rating scale. In: Fahn S, Marsden CD, Calne DB, editors. Recent developments in Parkinson's disease. London: Macmillan; 1987. p 153-63.
7. Ballard C, McKeith I, Burn D, et al. The UPDRS scale as a means of identifying extrapyramidal signs in patients suffering from dementia with Lewy bodies. Acta Neurol Scand 1997;96: 366-371.
8. Folstein M, Folstein S, McHugh PR. Mini-mental state. A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 1975;12:189-198.
9. Yesavage JA, Brink TL, Rose TL, et al. Development and validation of a geriatric depression screening scale: a preliminary report. J Psychiatr Res 1982;17:37-49.
10. Johns MW. Sleepiness, snoring and obstructive sleep apnoea: the Epworth sleepiness scale. Chest 1993;101:30-36.
11. Chaudhuri KR, Pal S, DiMarco A, et al. The Parkinson's disease sleep scale: a new instrument for assessing sleep and nocturnal disability in Parkinson's disease. J Neurol Neurosurg Psychiatry 2002;73:629-635.
12. Cummings JL, Mega M, Grey K, et al. The Neuropsychiatry inventory: comprehensive assessment of psychopathology in dementia. Neurology 1994;44:2308-2314.
13. Boeve BF, Silber MH, Ferman TJ. Current management of sleep disturbances in dementia. Curr Neurol Neurosci Rep 2002;2:169-177.
14. Grace JB, Walker MP, McKeith IG. A comparison of sleep profiles in patients with dementia with Lewy bodies and Alzheimer's disease. Int J Geriatr Psychiatry 2000;15:1023-1033.
15. Pal PK, Calne S, Samii A, et al. A review of normal sleep and its disturbances in Parkinson's disease. Park Relat Disord 1999;5: 1-17.
16. Bhatt MH, Podder N, Chokroverty S. Sleep and neurodegenerative diseases. Semin Neurol 2005;25:39-51.
17. Boddy F, Rowan EN, Lett D, et al. Subjectively reported sleep quality and excessive daytime somnolence in Parkinson's disease with and without dementia, dementia with Lewy bodies and Alzheimer's disease. Int J Geriatr Psychiatry 2006;21:1-7.
18. Fabbrini G, Barbanti P, Aurilia C, et al. Excessive daytime sleepiness in de novo and treated Parkinson's disease. Mov Disord 2002;17:1026-1030.
19. Ondo WG, Vuong D, Khan H. Daytime sleepiness and other sleep disorders in Parkinson's disease. Neurology 2001;57:1392-1396.
20. Arnulf I, Konofal E, Merino-Andreu M, et al. Parkinson's disease and sleepiness. Neurology 2002;58:1019-1024.
21. Arnulf I. Sleep and wakefulness disturbances in Parkinson's disease. J Neural Transm Suppl 2006;70:357-360.
22. Gomez-Esteban JC, Zarranz JJ, Lezcano E, et al. Sleep complaints and their relation with drug treatment in patients suffering from Parkinson's disease. Mov Disord 2006;21:983-988.
23. Andreu N, Chale JJ, Senard JM, et al. L-dopa induced sedation: a double blind cross-over controlled study versus triazolam and placebo in healthy volunteers. Clin Neuropharmacol 1999;22:15-23.
24. Hobson DE, Lang AE, Wayne Martin WR, et al. Excessive daytime sleepiness and sudden-onset sleep in Parkinson disease. JAMA 2002;287:455-463.
25. O'Suilleabhain PE, Dewey RB. Contributions of dopaminergic drugs and disease severity to daytime sleepiness in Parkinson disease. Arch Neurol 2002;59:986-989.
26. Kaynak D, Kiziltan G, Kaynak H, et al. Sleep and sleepiness in patients with Parkinson's disease before and after dopaminergic treatment. Eur J Neurol 2005;12:199-107.
27. Comella C. Sleep episodes in Parkinson's disease: more questions remain. Sleep Med 2003;4:267-268.